[Thiophosphamide-induced chromosome aberrations in embryonal liver and bone marrow cells of A/He and C57BL/L mice].
Chromosomal aberrations were studied in cells of embryonic liver and bone marrow of A/He and C57BL/6 mice following mutagenic treatment by the alkylating agent thiophosphamide in g1-S periods of the cell cycle. Higher sensitivity of chromosomes to aberration induction was found in A/He mice.
D000818:Animals; D001853:Bone Marrow; D002869:Chromosome Aberrations; D004622:Embryo, Mammalian; D005260:Female; D008099:Liver; D008297:Male; D051379:Mice; D008805:Mice, Inbred A; D008810:Mice, Inbred C57BL; D009153:Mutagens; D011247:Pregnancy; D013852:Thiotepa / Q000009:adverse effects*
D009153:Mutagens; D013852:Thiotepa
Khromosomnye aberratsii v kletkakh émbrional'noĭ pecheni i kostnogo mozga mysheĭ A/He i C57BL/6, indutsirovannye tiofosfamidom.